Skip to Main Content

Paper Details

Multi-site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos.
Clin Transl Sci
6
2021
CYP2C9, CYP2C9 variants, CYP4F2, CYP4F2 and NQO1 variants, CYP4F2*3, NQO1 variants, NQO1*2, Patients, VKORC1, VKORC1 and CYP2C9 variants, VKORC1 c.-, Warfarin, c, c.-1639G> A, warfarin
Author NameAffiliation
Nihal El RoubyDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida
Nihal El RoubyDepartment of Pharmacy Practice and Administrative Sciences, University of Cincinnati James L. Winkle College of Pharmacy
Heidi E SteinerDepartment of Pharmacy Practice and Science, University of Arizona College of Pharmacy
Steven A LubitzCardiac Arrhythmia Service and Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School
Steven A LubitzCardiac Arrhythmia Service and Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School
Stuart A ScottIcahn School of Medicine at Mount Sinai
Jason H KarnesFaculdade de Medicina FMUSP, Heart Institute (InCor), Universidade de Sao Paulo
Larisa H CavallariDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida
  • 1 - 8

Datasets